Patent application number | Description | Published |
20140066690 | Start-up Algorithm for an Implantable Blood Pump - A system and a method for starting a rotor of an implantable blood pump are described. For example, a blood pump system includes a rotary motor having a stator and a rotor. The rotor has permanent magnetic poles for magnetic levitation of the rotor, and the stator has a plurality of pole pieces arranged circumferentially at intervals. The blood pump system includes a controller configured to control a start phase of the rotor, wherein the start phase is prior to the rotor being positioned in a predefined geometric volume for pumping blood and wherein the start phase includes performing a rotation of the rotor by an angle larger than an angle corresponding to a quarter of an angular distance between two neighboring magnetic poles of the rotor. | 03-06-2014 |
20140066691 | Instability Detection Algorithm for an Implantable Blood Pump - An instability detection algorithm for an implantable blood pump may include determining a target position of a rotor of the pump, the rotor having permanent magnetic poles for magnetic levitation of the rotor, calculating a positional displacement of the target position from a predefined origin of a coordinate system of a housing of the pump, and calculating, during a rotation of the rotor, geometric deviations of a current position of the rotor from the target position. | 03-06-2014 |
20140067056 | Hall Sensor Mounting in an Implantable Blood Pump - A molded interconnect device can carry a Hall sensor for transducing a position of a rotor of the implantable blood pump. The molded interconnect device includes one or more integrated electronic circuit traces configured to electrically connect the hall sensor with a printed circuit board of the implantable blood pump, and the molded interconnect device is configured to be mounted to the printed circuit board. | 03-06-2014 |
20150290378 | METHODS AND SYSTEMS FOR LVAD OPERATION DURING COMMUNICATION LOSSES - Methods, systems, and devices for an adaptable blood pump are disclosed herein. The blood pump can be part of a mechanical circulatory support system that can include a system controller and the blood pump. The blood pump can include a rotary motor and a control unit that can communicate with the system controller. The blood pump can determine when communication with the system controller is established or has been lost. The blood pump can retrieve one or several back-up parameters when communication with the system controller has been lost, and can operate according to these back-up parameters. | 10-15-2015 |
Patent application number | Description | Published |
20130237553 | MULTICOMPONENT SYSTEM OF RESUVASTATIN CALCIUM SALT AND SORBITOL - A novel solid form of Rosuvastatin comprises as the active ingredient a salt of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)-amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid] and sorbitol. The crystal comprising the two components, and minor amounts of water, shows improved properties such as crystal-lization behaviour and stability. | 09-12-2013 |
20140031377 | MULTICOMPONENT CRYSTALLINE SYSTEM OF ROSUVASTATIN CALCIUM SALT AND VANILLIN - A novel solid form of Rosuvastatin comprises as the active ingredient a salt of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)-amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid] and vanillin or vanillin derivatives. The crystal comprising the two components, and minor amounts of water, shows improved properties such as crystallization behavior stability and decreased hydroscopic behavior. | 01-30-2014 |
20140155371 | MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE - Provided is a crystalline composition comprising a mixture of a compound of formula 1 (Ezetimibe) and proline or proline derivatives, or a hydrate/solvate thereof, as well as a process for obtaining the same. And a process for the purification of Ezetimibe is also disclosed. | 06-05-2014 |
20140194453 | MULTICOMPONENT CRYSTALLINE SYSTEM OF ROSUVASTATIN CALCIUM SALT AND VANILLIN - A novel solid form of Rosuvastatin comprises as the active ingredient a salt of bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)-amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid] and vanillin or vanillin derivatives. The crystal comprising the two components, and minor amounts of water, shows improved properties such as crystallization behavior stability and decreased hydroscopic behavior. | 07-10-2014 |
20150133463 | MULTICOMPONENT CRYSTALS COMPRISING DASATINIB AND SELECTED CO-CRYSTAL FORMERS - Provided are a multicomponent crystalline system (co-crystal), use thereof, as well as a process for obtaining the same. The said multicomponent crystalline system (co-crystal) comprises Dasatinib and a second compound selected from methyM-hydrobenzoate, nicotinamide, ethyl gallate, methyl gallate, propyl gallate, ethyl maltol, vanillin, menthol, or (1R,2S,5R)-(−)-menthol. | 05-14-2015 |